Bone transport using hydroxyapatite loaded with bone morphogenetic protein in rabbits

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 8, 2007, Pages 1122-1129

  Watanabe, K ^a   Tsuchiya, H ^a   Sakurakichi, K ^a   Tomita, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE CONDUCTION; BONE DEVELOPMENT; BONE PROSTHESIS; BONE REGENERATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RABBIT; RADIODIAGNOSIS; VASCULARIZATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DURAPATITE; OSTEOGENESIS, DISTRACTION; PERIOSTEUM; RABBITS; TIBIA;

EID: 34848865051     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B8.19003     Document Type: Article

References (46)

1. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues. Part I: the influence of stability of fixation and soft tissue preservation. Clin Orthop 1989;238:249-81.
2. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues. Part II: the influence of the rate and frequency of distraction. Clin Orthop 1989;239:263-85.
3. Tsuchiya H, Tomita K, Minematsu K, et al. Limb salvage using distraction osteogenesis: a classification of the technique. J Bone Joint Surg [Br] 1997;79-B:403-11.
4. Tsuchiya H, Abdel-Wanis ME, Sakurakichi K, Yamashiro T, Tomita K. Osteosarcoma around the knee: intraepiphyseal excision and biological reconstruction with distraction osteogenesis. J Bone Joint Surg [Br] 2002;84-B:1162-6.
5. Tsuchiya HJ, Tomita K. Distraction osteogenesis for treatment of bone loss in the lower extremity. J Orthop Sci 2003;8:116-24.
6. Friedlaender GE, Strong DM, Tomford WW, Mankin HJ. Long-term follow-up of patients with osteochondral allografts: a correlation between immunologic responses and clinical outcome. Orthop Clin North Am 1999;30:583-8.
7. Manabe J, Ahmed AR, Kawaguchi N, Matsumoto S, Kuroda H. Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop 2004;419:258-66.
8. Thompson VP, Steggall CT. Chondrosarcoma of the proximal portion of the femur treated by resection and bone replacement: a six-year result. J Bone Joint Surg [Am] 1956;38-A:357-07.
9. Yamamuro T, Kotoura Y. Intraoperative radiation therapy for osteosarcoma. Cancer Treat Res 1993;39:623-30.
10. Tsuchiya H, Sakurakichi K, Yamashiro T, et al. Bone transport with frozen devitalized bone: an experimental study using rabbits and a clinical application. J Orthop Sci 2004;9:619-24.
11. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6.
12. Marciani RD, Giansanti JS, Massey GB. Reimplantation of freeze-treated and saline-treated mandibular bone. J Oral Surg 1976;34:314-19.
13. Yamamoto N, Tsuchiya H, Tomita K. Effects of liquid nitrogen treatment on the proliferation of osteosarcoma and biomechanical properties of normal bone. J Orthop Sci 2003;8:374-80.
14. Kinoshita A, Oda S, Takahashi K, Tokota S, Ishikawa I. Peridontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J Peridontal 1997;68:103-9.
15. Takahashi D, Odajima T, Morita M, Kawanami M, Kato H. Formation and resolution of ankylosis under appliction of recombinant human bone morphogenetic protein-2 (rhBMP-2) to class III forcation defects in cats. J Periodontal Res 2005;40:299-305.
16. Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I. Bone regeneration by recombinant humam bone morphogenetic protein-2 in rat mandible defects: an experimental model of defect filling. J Periodontal 1999;70:1026-31.
17. Itoh T, Mochizuki M, Nishimura R, et al. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J Vet Med Sci 1998;60:451-8.
18. No authors listed. Fundamental guidelines for proper conduct of animal experiments and related activites in academic research institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology. http://www.lifescience.mext.go.jp/policies/pdf/an_material011.pdf (date last accessed 13 August 2007).
19. Aronson J, Good B, Stewart C, Harrison B, Harp J. Preliminary studies of mineralization during distraction osteogenesis. Clin Orthop 1990;250:43-9.
20. Yasui N, Sato M, Ochi T, et al. Three modes of ossification during distraction osteogenesis in the rat. J Bone Joint Surg [Br] 1997;79-B:824-30.
21. Caplan AI. The mesengenic process. Clin Plast Surg 1994;21:429-35.
22. Ougushi H, Caplan AI. Stem cell technology and ceramics: from cell to gene engineering. J Biomed Mater Res 1999;48:913-27.
23. Noshi T, Yoshikawa T, Dohi Y, et al. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of narrow/hydroxyapatite composites. Artif Organ 2001;25:201-8.
24. Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfal. Endocr Rev 2000;21:393-411.
25. Jin Y, Yang L, White FH. An immunocytochemical study of bone morphpgenetic protein in experimental fracture healing of the rabbit mandible. Chin Med Sci J 1994;9:91-5.
26. Nakase T, Nomura S, Yoshikawa H, et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994;9:651-9.
27. Thies RS, Bauduy M, Ashton BA, et al. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992;130:1318-24.
28. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-66.
29. Nakase T, Takaoka K, Masuhara K, et al. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 1997;21:17-21.
30. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-7.
31. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Manidbular reconstruction with a recombinant bone-inducing factor: functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991;117:1101-12.
32. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993;293:317-26.
33. Okazaki H, Kurokawa T, Nakamura K, et al. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int 1999;64:542-6.
34. Hamdy RC, Amako M, Beckman L, et al. Effects of osteogenic protein-1 on distraction osteogenesis in rabbits. Bone 2003;33:248-55.
35. Mizumoto Y, Moseley T, Drews M, Cooper VN, Reddi AH. Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7. J Bone Joint Surg [Am] 2003;85-A(Suppl 3):124-30.
36. Ashinoff RL, Cetrulo CL Jr, Galiano RD, et al. Bone morphogenetic protein-2 gene therapy for mandibular distraction osteogenesis. Ann Plast Surg 2004;52:585-90.
37. Stewart KJ, Weyand B, van't Hof RJ, et al. A quantitative analysis of the effect of insulin-like factor-1 infusion during mandibular distraction osteogenesis in rabbits. Br J Plast Surg 1999;52:343-50.
38. Ohgushi H, Dohi Y, Tamai S, Tabata S. Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Bes 1993;27:1401-7.
39. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic: experiments in rats. Acta Orthop Scand 1989;60:334-9.
40. De Bastiani G, Aldegheri R, Renzi-Brivio L, Trivella G. Limb lengthening by callus distraction (callotasis). J Pediatr Orthop 1987;7:129-34.
41. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002;27(Suppl 1):16-23.
42. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002;84-A:2123-34.
43. Windhager R, Tsuboyama T, Siegle H, et al. Effect of bone cylinder length on distraction osteogenesis in the rabbit tibia. J Orthop Res 1995;13:620-8.
44. Tatsuyama K, Maezawa Y, Baba H, Imamura Y, Fukuda M. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 2000;44:269-78.
45. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth facgtor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002;9:9656-61.
46. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor. Endocrinology 2002;143:1545-53.